Soy Estrogen Alternative Study (SEA)

• Status: Completed
• Trial end date: 1998-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

To conduct a three-armed trial assessing the effect of soy phytoestrogens on menopausal complaints, plasma lipids and lipoproteins, vaginal bleeding and endometrial proliferation, and health related quality of life.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
• Treatments: Estrogens; Estrogens, Conjugated (USP)

Criteria

Perimenopausal/menopausal women, ages 45 to 55.